Human fibrinogen

During the coagulation process, fibrinogen is hydrolyzed by thrombin into fibrin. Under the action of fibrin-stabilizing factor (FXIII), solid fibrin is formed, which plays an effective hemostatic role.

Main components: human fibrinogen.

This product is a loose body of off-white or light yellow. After reconstitution, it should be a clear liquid with a slight opalescence.

1. Congenital hypofibrinogenemia or deficiency. 2. Acquired hypofibrinogenemia: severe liver damage; liver cirrhosis; disseminated intravascular coagulation; postpartum hemorrhage and coagulation disorders caused by fibrinogen deficiency due to major surgery, trauma or internal bleeding.

Usage: Preheat the product and sterile water for injection to 30-37℃ before use, then inject the preheated sterile water for injection according to the amount indicated on the bottle label, place in a 30-37℃ water bath, and gently shake to dissolve the product completely (avoid violent shaking to avoid protein denaturation). Use an infusion set with a filter device for intravenous drip. The drip rate is generally about 60 drops per minute. Dosage: It should be determined according to the condition and clinical test results. Generally, 1-2g is given for the first time. If necessary, continue to give the drug according to the doctor's advice.

Generally there are no adverse reactions. Only a few patients with allergic constitutions will experience allergic reactions. Emergency treatment measures should be taken for those with severe reactions.

There are no known contraindications when the indications are strictly controlled.

Precautions for children: No research data available. Precautions for pregnancy and lactation: Pregnant and lactating women should use the drug with caution. It should only be used when it is necessary for the patient after weighing the pros and cons, and should be used under the guidance of a physician and close observation. Precautions for the elderly: No research data available.

Do not use with other medicines.

It should be stored in a dry place away from light at a temperature below 10°C. Use within the expiration date indicated on the bottle label.

0.5g/bottle

24 months

Harbin Pesfico Biopharmaceutical Co., Ltd.

• Founded in:

  1992-05-27

• Address:

  No. 77 Siping Road, Limin Economic and Technological Development Zone, Harbin

• Tax NO.:

  91230100607160107E

• Registered Funds:

  80.871606 million yuan

• Website:

  Log in to view

• Email:

  Log in to view